Skip to main content
Erschienen in: Virchows Archiv 2/2021

05.11.2020 | Brief Report

Spiradenoma of the breast: a rare diagnostic pitfall in the evaluation of solid-basaloid breast lesions with a dual cell population

verfasst von: Hirofumi Matsumoto, Reika Takamatsu, Norie Abe, Mikiko Unesoko, Hisamitsu Zaha, Akiko Ishii, Norihiro Nakada, Hiroshi Nishihara, Puay Hoon Tan, Naoki Yoshimi

Erschienen in: Virchows Archiv | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Breast spiradenoma is extremely rare, with only 4 cases reported previously. We describe an instructive case of breast spiradenoma resembling adenoid cystic carcinoma (AdCC). A 71-year-old woman underwent excisional biopsy of a breast mass after a conclusive diagnosis was unable to be obtained from core needle biopsy showing an AdCC-like pattern. Histopathologically, the lesion demonstrated solid and cribriform foci comprising basaloid cells, luminal cells, and eosinophilic hyaline material, reminiscent of solid-basaloid AdCC, alongside convoluted lumens, stromal edema, lymphocytic infiltration, and c-kit negativity. On molecular analysis, neither MYB fusion genes nor CYLD gene abnormalities were identified. These results were supportive of spiradenoma. Salivary gland– and skin adnexal–type tumors are challenging to diagnose due to morphological overlaps. This case, highlighting histopathological and molecular features, shows that breast spiradenoma can be a diagnostic pitfall among the differential diagnoses of AdCC.
Literatur
1.
Zurück zum Zitat Who Classification of Tumours Editorial Board (ed) (2019) WHO classification of tumours of the breast, 5th edn. International Agency for Research on Cancer, Lyon Who Classification of Tumours Editorial Board (ed) (2019) WHO classification of tumours of the breast, 5th edn. International Agency for Research on Cancer, Lyon
3.
Zurück zum Zitat Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM (2002) Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome. Cancer 94:2119–2127CrossRef Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM (2002) Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome. Cancer 94:2119–2127CrossRef
4.
Zurück zum Zitat Ribeiro-Silva A, Shaletich C, Careta RS, Kazava DK, Siqueira MC, Ponton F (2004) Spiradenocarcinoma of the breast arising in a long-standing spiradenoma. Ann Diagn Pathol 8:162–166CrossRef Ribeiro-Silva A, Shaletich C, Careta RS, Kazava DK, Siqueira MC, Ponton F (2004) Spiradenocarcinoma of the breast arising in a long-standing spiradenoma. Ann Diagn Pathol 8:162–166CrossRef
5.
Zurück zum Zitat Saboorian MH, Kenny M, Ashfaq R, Albores-Saavedra J (1996) Carcinosarcoma arising in eccrine spiradenoma of the breast. Report of a case and review of the literature. Arch Pathol Lab Med 120:501–504PubMed Saboorian MH, Kenny M, Ashfaq R, Albores-Saavedra J (1996) Carcinosarcoma arising in eccrine spiradenoma of the breast. Report of a case and review of the literature. Arch Pathol Lab Med 120:501–504PubMed
6.
Zurück zum Zitat Panico L, D'Antonio A, Chiacchio R, Delrio P, Petrella G, Pettinato G (1996) An unusual, recurring breast tumor with features of eccrine spiradenoma: a case report. Am J Clin Pathol 106:665–669CrossRef Panico L, D'Antonio A, Chiacchio R, Delrio P, Petrella G, Pettinato G (1996) An unusual, recurring breast tumor with features of eccrine spiradenoma: a case report. Am J Clin Pathol 106:665–669CrossRef
7.
Zurück zum Zitat Bosch MM, Boon ME (1992) Fine-needle cytology of an eccrine spiradenoma of the breast: diagnosis made by a holistic approach. Diagn Cytopathol 8:366–368CrossRef Bosch MM, Boon ME (1992) Fine-needle cytology of an eccrine spiradenoma of the breast: diagnosis made by a holistic approach. Diagn Cytopathol 8:366–368CrossRef
11.
Zurück zum Zitat Rashid M, van der Horst M, Mentzel T, Butera F, Ferreira I, Pance A, Rütten A, Luzar B, Marusic Z, de Saint AN, Ko JS, Billings SD, Chen S, Abi Daoud M, Hewinson J, Louzada S, Harms PW, Cerretelli G, Robles-Espinoza CD, Patel RM, van der Weyden L, Bakal C, Hornick JL, Arends MJ, Brenn T, Adams DJ (2019) ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma. Nat Commun 10:2213. https://doi.org/10.1038/s41467-019-09979-0CrossRefPubMedPubMedCentral Rashid M, van der Horst M, Mentzel T, Butera F, Ferreira I, Pance A, Rütten A, Luzar B, Marusic Z, de Saint AN, Ko JS, Billings SD, Chen S, Abi Daoud M, Hewinson J, Louzada S, Harms PW, Cerretelli G, Robles-Espinoza CD, Patel RM, van der Weyden L, Bakal C, Hornick JL, Arends MJ, Brenn T, Adams DJ (2019) ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma. Nat Commun 10:2213. https://​doi.​org/​10.​1038/​s41467-019-09979-0CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Leonard N, Chaggar R, Jones C, Takahashi M, Nikitopoulou A, Lakhani SR (2001) Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours. J Clin Pathol 54:689–692CrossRef Leonard N, Chaggar R, Jones C, Takahashi M, Nikitopoulou A, Lakhani SR (2001) Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours. J Clin Pathol 54:689–692CrossRef
13.
Zurück zum Zitat Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, Heguy A, Viale A, Drobnjak M, Leversha MA, Rice CE, Singh B, Iyer NG, Leemans CR, Bloemena E, Ferris RL, Seethala RR, Gross BE, Liang Y, Sinha R, Peng L, Raphael BJ, Turcan S, Gong Y, Schultz N, Kim S, Chiosea S, Shah JP, Sander C, Lee W, Chan TA (2013) The mutational landscape of adenoid cystic carcinoma. Nat Genet 45:791–798. https://doi.org/10.1038/ng.2643CrossRefPubMedPubMedCentral Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, Ramaswami D, Walsh LA, Eng S, Huse JT, Zhang J, Dolgalev I, Huberman K, Heguy A, Viale A, Drobnjak M, Leversha MA, Rice CE, Singh B, Iyer NG, Leemans CR, Bloemena E, Ferris RL, Seethala RR, Gross BE, Liang Y, Sinha R, Peng L, Raphael BJ, Turcan S, Gong Y, Schultz N, Kim S, Chiosea S, Shah JP, Sander C, Lee W, Chan TA (2013) The mutational landscape of adenoid cystic carcinoma. Nat Genet 45:791–798. https://​doi.​org/​10.​1038/​ng.​2643CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Fusco N, Colombo PE, Martelotto LG, De Filippo MR, Piscuoglio S, Ng CK, Lim RS, Jacot W, Vincent-Salomon A, Reis-Filho JS, Weigelt B (2016) Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing. Histopathology 68:262–271. https://doi.org/10.1111/his.12735CrossRefPubMed Fusco N, Colombo PE, Martelotto LG, De Filippo MR, Piscuoglio S, Ng CK, Lim RS, Jacot W, Vincent-Salomon A, Reis-Filho JS, Weigelt B (2016) Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing. Histopathology 68:262–271. https://​doi.​org/​10.​1111/​his.​12735CrossRefPubMed
Metadaten
Titel
Spiradenoma of the breast: a rare diagnostic pitfall in the evaluation of solid-basaloid breast lesions with a dual cell population
verfasst von
Hirofumi Matsumoto
Reika Takamatsu
Norie Abe
Mikiko Unesoko
Hisamitsu Zaha
Akiko Ishii
Norihiro Nakada
Hiroshi Nishihara
Puay Hoon Tan
Naoki Yoshimi
Publikationsdatum
05.11.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 2/2021
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-020-02958-7

Weitere Artikel der Ausgabe 2/2021

Virchows Archiv 2/2021 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …